Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ·Healthcare·Biotechnology
$15.35
+0.99%
Mkt Cap $1.85B
Analyst Ratings
Buy
5
Hold
1
Sell
0
Price Target (10 analysts)
$15.00
Range $14.00 – $16.00
Implied Upside
-2.3%
Consensus $15.00 vs current $15.35
NASDAQ·Healthcare·Biotechnology
$15.35
+0.99%
Mkt Cap $1.85B
Buy
5
Hold
1
Sell
0
Price Target (10 analysts)
$15.00
Range $14.00 – $16.00
-2.3%
Consensus $15.00 vs current $15.35